Acadia Pharmaceuticals reported $759M in Assets for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acadia Pharmaceuticals ACAD:US $ 759M 12M
Adamas Pharmaceuticals ADMS:US $ 347M 75M
Alexion Pharmaceuticals ALXN:US $ 16703.2M 1445.3M
ALKERMES ALKS:US $ 1876.82M 74.48M
Alnylam Pharmaceuticals ALNY:US $ 3307.28M 67.08M
Biogen BIIB:US $ 24934.1M 577.7M
Biomarin Pharmaceutical BMRN:US $ 5302.11M 579.27M
Bristol Myers Squibb BMY:US $ 128076M 1209M
Corcept Therapeutics CORT:US $ 497M 52M
Cytokinetics CYTK:US $ 474.11M 241.62M
Eisai 4523:JP Y 1040296M 21844M
Eli Lilly And LLY:US $ 41967M 864.2M
Gw Pharmaceuticals GWPH:US $ 910.26M 39.68M
Intercept Pharmaceuticals ICPT:US $ 637.49M 24.89M
Johnson & Johnson JNJ:US $ 170693M 12313M
Neurocrine Biosciences NBIX:US $ 1515M 154M
Pfizer PFE:US $ 177934M 11598M
Prothena PRTA:US $ 355.78M 23.15M
Ptc Therapeutics PTCT:US $ 1476.64M 68.96M
Sarepta Therapeutics SRPT:US $ 2883M 64M
Seattle Genetics SGEN:US $ 3004.96M 840.4M
Ultragenyx Pharmaceutical RARE:US $ 1314.04M 80.9M
Vanda Pharmaceuticals VNDA:US $ 506.63M 18.11M
Vertex Pharmaceuticals VRTX:US $ 10216.37M 1323.17M
YTE INCY:US $ 3212.32M 459.9M
Zogenix ZGNX:US $ 555M 51M